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ABSTRACT 
Therapies to extend healthspan are poised to move from laboratory animal models to human 
clinical trials. Translation from mouse to human will entail challenges, among them the 
multifactorial heterogeneity of human aging. To inform clinical trials about this heterogeneity, 
we report how humans’ pace of biological aging relates to personal-history characteristics. 
Because geroprotective therapies must be delivered by midlife to prevent age-related disease 
onset, we studied young-adult members of the Dunedin Study 1972-73 birth cohort (n=954). 
Cohort members’ Pace of Aging was measured as coordinated decline in the integrity of 
multiple organ systems, by quantifying rate of decline across repeated measurements of 18 
biomarkers assayed when cohort members were ages 26, 32, and 38 years. The childhood 
personal-history characteristics studied were known predictors of age-related disease and 
mortality, and were measured prospectively during childhood. Personal-history characteristics 
of familial longevity, childhood social-class, adverse childhood experiences, and childhood 
health, intelligence, and self-control all predicted differences in cohort members’ adulthood 
Pace of Aging. Accumulation of more personal-history risks predicted faster Pace of Aging. 
Because trials of anti-aging therapies will need to ascertain personal histories retrospectively, 
we replicated results using cohort members’ retrospective personal-history reports made in 
adulthood. Because many trials recruit participants from clinical settings, we replicated results 
in the cohort subset who had recent health-system contact according to electronic medical 
records. Quick, inexpensive measures of trial participants’ early personal histories can enable 
clinical trials to study who volunteers for trials, who adheres to treatment, and who responds to 
anti-aging therapies.   
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INTRODUCTION 
The prevalence of many chronic diseases increases steeply with advancing chronological 
age (Belsky, Caspi, Houts, et al. 2015). Thus, aging itself can be considered a leading disease risk 
factor (López-Otín et al. 2013; Kaeberlein 2013). This observation implies that interventions to 
slow biological aging could delay all age-related diseases simultaneously (Kirkland 2013), 
reducing late-life multi-morbidity (Barnett et al. 2012) and extending years lived free of disease 
and disability, called “healthspan” (Burch et al. 2014). The aging global population makes 
development of healthspan-extending interventions a public health priority (Harper 2014). 
Researchers pioneering geroprotective therapies in animals appear poised to deliver these 
therapies to human trials (de Cabo et al. 2014; Longo et al. 2015). But human translation of 
therapies to slow the biological process of aging will face challenges (Moskalev et al. 2016).   
One likely challenge to translation from mouse to man is that free-living humans are 
heterogeneous as compared to laboratory-based model organisms. The experimental 
geroscience of extending animal lifespan has rarely studied individual heterogeneity in the pace 
of aging.  Genetically identical animals living under uniform laboratory conditions tend to age at 
the same pace, leaving the experimentally applied treatment as the main source of variation in 
pace of aging. In contrast, humans’ pace of biological aging is multifactorial and may be sped or 
slowed by personal-history characteristics that accumulate from early life (Kirkwood & Austad 
2000; Gavrilov & Gavrilova 2004; Gladyshev 2016). As examples, familial longevity (Perls & Terry 
2003; Atzmon et al. 2004),  childhood social disadvantage and adverse experiences (Felitti et al. 
1998; Hayward & Gorman 2004), and childhood traits including poor health and low 
intelligence (Case et al. 2005; Calvin et al. 2011) forecast later-life disease and mortality.  
Studying personal-history characteristics that may influence the pace of biological aging 
is important, at least in part, because personal characteristics have the capacity to impact 
translation from preclinical healthspan models to humans (Guarente 2014; Pitt & Kaeberlein 
2015). First, personal-history characteristics related to the pace of aging are known to influence 
the propensity to volunteer for trials, as well as the likelihood of completing protocols and 
adhering to treatment regimens. Second, personal histories may influence response to 
treatment. To demonstrate the benefit of potential geroprotective treatments for improving 
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public health, at least some trials will need to recruit individuals with personal histories of 
adverse exposure to effectively represent populations most needing healthspan-extending 
therapies (Figure 1). Likewise, advantaged personal histories could identify individuals who are 
already aging slowly, and are unlikely to benefit from treatment. Third, randomized clinical 
trails are obliged to register in advance participant characteristics to be analyzed as potential 
moderators of treatment outcome. Trials will need to collect data on such characteristics. 
Information about personal-history characteristics that influence the pace of human aging 
could thus improve trial design. 
 We tested the hypothesis that worse scores on personal-history characteristics would 
predict a faster pace of biological aging among 954 members of the 1972-73 Dunedin (New 
Zealand) birth cohort, who have now reached approximately the midpoint of the contemporary 
human lifespan. We studied a midlife cohort because this is the age group for whom age-
delaying therapies can still delay the onset of chronic disease. For example, this midlife strategy 
was adopted  by the first human trial of caloric restriction as an intervention designed to extend 
healthspan (Ravussin et al. 2015).  
We measured the pace of biological aging from changes in 18 biomarkers of cohort 
members’ cardiovascular, metabolic, endocrine, pulmonary, hepatic, renal, immune, and 
periodontal systems. These 18 biomarkers were measured repeatedly across 12 years, at three 
time points when the cohort members were aged 26, 32, and 38 years. We use these data to 
measure decline that occurs simultaneously across multiple biomarkers. By studying repeated 
measures of biomarkers over time, we can distinguish age-related changes from baseline 
differences that reflect prior health status. By studying changes in multiple biomarkers 
together, we can distinguish age-related loss of system integrity from spikes in particular 
biomarkers caused by acute illness. Our measure, called the “Pace of Aging,” operationalizes 
the coordinated progressive loss of integrity across bodily systems that geroscience theory 
specifies as the aging process (Belsky, Caspi, Houts, et al. 2015). Measured Pace of Aging is not a 
cause of biological aging; it is a measurement of differences among individuals in their rate of 
biological aging during our 12-year observation window. The Pace of Aging quantifies Study 
members’ rate of biological aging in year-equivalent units of physiological decline occurring per 
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chronological year. The average Study member experienced one year of physiological decline 
per each chronological year, a Pace of Aging of 1. The fastest-aging Study members experienced 
more than twice this rate of change, while the slowest-aging Study members experienced 
almost no change at all.  
Our analysis tested relationships of personal-history characteristics with Pace of Aging. 
The six characteristics were familial longevity, childhood social-class, adverse childhood 
experiences, and childhood health, intelligence, and self-control. We selected these 
characteristics because each has an established link to morbidity and mortality (Felitti et al. 
1998; Hayward & Gorman 2004; Case et al. 2005; Calvin et al. 2011; Atzmon et al. 2004; 
Friedman et al. 1993). We focused on familial and childhood measures because of evidence 
that early-life exposures increase risk for diseases that reduce healthspan (Power et al. 2013). 
Early-life measures also have the advantage of being temporally antecedent to the biomarkers 
that we used to quantify Study members’ pace of biological aging; this eliminated the possibility 
of reverse causation. Finally, we selected early-life characteristics that clinical trials are able to 
ascertain from trial participants; e.g., we did not test low birth weight because it is difficult to 
ascertain by retrospective report. We measured the six personal-history characteristics using 
prospective data collected during childhood waves of the Study. However, knowing that few 
trials will have access to childhood measurements, we also conducted a parallel analysis using 
measurements taken retrospectively, when Study members were adults.  
 
RESULTS 
  
Personal histories predict adults’ Pace of Aging. 
To test if Study members’ personal-history characteristics were related to their Pace of Aging, 
we examined 6 characteristics. Grandparental longevity was measured as the oldest age to 
which any biological grandparent had survived. Childhood social class was defined from the 
occupations of Study members’ parents when Study members were children. Adverse 
childhood experiences (ACEs) were defined according to the US Centers for Disease Control and 
Prevention criteria (Felitti et al. 1998). Childhood health was measured as a combination of 
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examinations, nurse ratings, and clinical interviews with parents (Belsky, Caspi, Israel, et al. 
2015).  Childhood IQ was measured using the Wechsler Intelligence Scales for Children 
(Wechsler 2003). Childhood self-control was measured as a combination of staff observations, 
and parent-, teacher-, and children’s own reports (Moffitt et al. 2011).   
Study members with shorter-lived grandparents, who grew up in lower-social class 
homes, who experienced more ACEs, who had poorer childhood health, who scored lower on 
IQ tests, and who had poorer self-control all showed evidence of accelerated biological aging 
during their 20s and 30s (Pearson’s r range r=0.10–0.23, Figure 2).  
 Childhood risk characteristics tend to cluster within individuals, and their accumulation 
is known to influence later outcomes (Evans et al. 2013). Therefore, we tested if accumulations 
of personal-history risks differentiated rapidly aging Study members from their slower-aging 
peers.  To calculate a cumulative risk score, personal-history measures were standardized to a 
T-distribution (mean=50, SD=10) and summed. (A study member with average levels of all 6 risk 
characteristics would have a cumulative risk score of 50 x 6 = 300.) Study members with higher 
cumulative personal-history risk experienced faster Pace of Aging as compared to peers with a 
lower cumulative risk (r=0.27, p<0.001). Figure 3 shows how cumulative risk differed between 
slower- and faster-aging Study members. For graphing purposes, in Figure 3, Study members 
were divided into three groups based on Pace of Aging: a slow-aging group with Pace of Aging 
≤1 SD below the mean (less than about 0.6 years of physiological change or less per 
chronological year; n=117); an average-aging group with Pace of Aging within 1 SD of the mean 
(about 0.6-1.4 years of physiological change per chronological year; n=708); and a fast-aging 
group with Pace of Aging ≥1 SD above the mean (more than about 1.4 years of physiological 
change per chronological year; n=129). Most slow-aging Study members had no high-risk 
characteristics. In contrast, more than 40% of fast-aging Study members were classified as high-
risk on multiple family and childhood characteristics.    
 
Can personal histories be measured in adults enrolling in trials of therapies to slow aging?  
Clinical trials of therapies to slow aging are likely to lack prospective measures taken when 
enrollees were children; for example, few adults have records of their childhood IQ. Therefore, 
Impact of Early Personal History Characteristics on the Pace of Aging 
 7 
analyses were repeated using contemporaneous assessments of personal-history 
characteristics taken after Dunedin Study members became adults. We classified each Study 
member as high or low risk on each of the personal-history characteristics using quick, 
inexpensive measurements. We used adulthood reports of whether any biological grandparent 
had lived past age 80 years to assess familial longevity; adulthood recollections of Study 
members’ parents’ occupations during their childhoods to assess childhood social class; 
retrospective interviews to count ACE exposures; and educational attainment as a proxy for 
childhood IQ.  To assess the adult equivalent of self-control, we used brief ratings of adult Study 
members’ conscientious personality made by nurses during physical exams. (Memories of 
childhood health were not queried from Study members as adults.) Contemporaneously 
assessed history of cumulative risk was related to Pace of Aging; Study members with more 
personal-history risk characteristics had faster Pace of Aging (r=0.21, p<0.001). This association 
was similar to, but slightly weaker than the association between prospectively measured risk 
and Pace of Aging (r=0.27). 
Some clinical trials of geroprotective therapies may wish to recruit volunteers from 
clinical settings. To assess whether personal histories would predict pace of aging similarly in 
such individuals, we tested the association between personal-history risk and Pace of Aging in 
Dunedin Study members who had recent contact with healthcare providers (Figure 4).  One 
group comprised Study members with recent prescription fills. Another group comprised Study 
members with recent hospital admissions. Both groups were identified via record-linkage with 
national health system electronic medical records. Within these groups that may better-reflect 
adults available for recruitment into clinical trials, more personal-history risk characteristics 
predicted faster Pace of Aging. 
Because educational attainment is only a crude proxy for childhood intelligence, and 
because some clinical trial samples will be relatively homogeneous in their educational 
attainment, we repeated our analysis substituting, in place of low education, a 2-minute, non-
verbal paper-and-pencil test of processing speed (WAIS digit-symbol coding (Wechsler 2008)). 
Processing speed predicts mortality (Swan et al. 1995) and is appealing because of its ease of 
measurement. Results were unchanged (Supplemental Figure 1).   
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In the interest of maximizing reproducibility of the results reported here, we repeated 
our analysis using two alternative algorithms to index biological aging. The Biological Age 
algorithm was originally developed using the US Centers for Disease Control and Prevention 
National Health and Nutrition Surveys (Levine 2013). The Age-related Homeostatic 
Dysregulation algorithm was originally developed using the Women’s Health and Aging, 
Baltimore Longitudinal Study, and InCHIANTI cohorts (Cohen et al. 2013). Each algorithm 
combines data on multiple biomarkers, but from a single cross-section of biomarker data. We 
applied these algorithms to biomarker data collected when Study members were aged 38 years. 
Study members with faster Pace of Aging were measured as having older Biological Age (r=0.38, 
p<0.001) (Belsky, Caspi, Houts, et al. 2015). They also showed greater age-related homeostatic 
dysregulation (r=0.58, p<0.001). Personal-history characteristics showed similar patterns of 
association with these two cross-sectional indexes as they did with the longitudinal Pace of 
Aging (Supplemental Figures 2-7).  
 
DISCUSSION 
Therapies to extend healthspan are poised to move from laboratory-based model systems to 
trials in humans (de Cabo et al. 2014; Longo et al. 2015). Such human translation faces hurdles, 
including the substantial heterogeneity of human aging. To advance understanding of this 
heterogeneity, we studied how six personal-history characteristics with documented 
relationships to later-life morbidity and mortality predicted the pace of biological aging. We 
studied the pace of aging in young adult humans (aged 26-38 years) because therapies will 
need to be delivered by midlife in order to prevent age-related disease. Our principle finding is 
that young adults who show signs of rapid biological aging are characterized by personal-history 
risks. Measuring future trial participants’ personal-history characteristics will be important to 
designing rigorous tests of age-delaying therapies.   
We measured biological aging as the coordinated decline in integrity of multiple organ 
systems. We quantified the rate of this decline, the “Pace of Aging” from repeated 
measurements of a panel of 18 biomarkers assayed when Study members were aged 26, 32, 
and 38 years (Belsky, Caspi, Houts, et al. 2015). We measured personal histories, background 
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characteristics hypothesized to influence biological aging, from archival data collected 
prospectively beginning during Study members’ childhoods.  Study members’ familial longevity, 
childhood social class, childhood adverse experiences, and childhood health, intelligence, and 
self-control were all related to their adulthood Pace of Aging. The relationship between 
personal-history risks (e.g. adverse childhood experiences, low IQ) and biological aging was 
cumulative; more risks predicted faster Pace of Aging. This pattern of results was replicated 
when personal-history risks were ascertained using quick, inexpensive contemporaneous 
measures, including adult Study members’ retrospective reports. The relationship between 
cumulative risk and faster Pace of Aging was similar in the subset of individuals with recent 
health-system contact, who presumably better represent the population eligible to enroll in 
healthspan-extension trials.  
A primary implication of these findings is that healthspan-extension trials can measure 
personal histories as one method to quantify heterogeneity in aging among potential 
participants. Measured personal histories may be useful to trials in at least four ways. First, 
enrolling participants with high personal-history risk helps to ensure a trial includes participants 
who represent the population segment most in need of therapy. This is because individuals 
with high levels of personal-history risk appear to be aging more rapidly and therefore will 
more urgently require healthspan-extending interventions. Second, personal-history 
information can inform evaluation of trial protocols. For example, personal-history risks could 
be evaluated as predictors of adherence. Third, personal-history characteristics, as sources of 
etiologic heterogeneity in aging, represent potential sources of variation in treatment response. 
Therefore these characteristics may be useful to pre-register as treatment-effect modifiers. In 
other branches of medicine, personal-history characteristics have been found to predict 
treatment response (Nanni et al. 2012). Fourth, personal histories can be ascertained cheaply 
and quickly. For example, our contemporaneous assessments (Supplemental Table 1) required 
less than three minutes of the participants’ time.  
If healthspan-extension trials do adopt personal-history assessments, they will need 
new team members. To date, interdisciplinarity in geroscience typically means biologists 
working with physicians. That collaboration is essential. Our findings argue that behavioral 
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scientists too have a place in the design and conduct of healthspan-extension trials. Tackling the 
challenge of translating healthspan-extension therapies from worms, flies, and mice to free-
living humans will require geroscience teams with behavioral expertise (Staudinger 2015). 
A secondary implication is that individuals with high personal-history risk may be well 
represented in populations seeking health care, and therefore should be available to enroll in 
trials. In the Dunedin cohort, individuals with recent prescription fills, and even those with 
recent hospital admissions showed similar or even elevated personal-history risks relative to 
the cohort overall. An important question for future research is if these high-risk individuals will 
be willing to volunteer for trials and able to adhere to protocols. Midlife patients seeking care in 
medical centers could be surveyed on personal-history characteristics (and willingness to 
volunteer) to create a subject pool for healthspan-extension trials.  
Our findings also have implications for etiological theories relating early-life risk 
exposures to later-life morbidity and mortality. Life-course epidemiology and the study of 
developmental origins of health and disease document the link between early-life adversity and 
later-life disease and death (Ben-Shlomo & Kuh 2002; Gluckman & Hanson 2004). Stress biology 
theory predicts this link is mediated by a process of “biological embedding” (Danese & McEwen 
2012). Here, we provide evidence consistent with a hypothesis that biological embedding 
occurs through an acceleration of the aging process during the third and fourth decades of life. 
Intervention to slow aging may provide a path to mitigate damage caused by early adversity.  
We acknowledge limitations. First, we studied a single New Zealand birth cohort that 
lacked ethnic minority representation. Replications are needed. Second, follow-up was right 
censored at the fifth decade of life. Study members aging slowly during their third and fourth 
decades of life might experience acceleration subsequently. Similarly, more rapidly aging Study 
members might experience a slowed Pace of Aging in later years. Analysis in cohorts of older 
individuals is needed. Third, our analysis concerned only risks accruing through childhood. We 
selected personal-history characteristics from early life to establish temporal precedence of 
personal histories to Pace of Aging measured during Study members’ 20s and 30s. However, 
adolescent and young-adult lifestyles and health behaviors likely influence aging and should 
also be measured as sources of heterogeneity in clinical trials. Our analysis also omitted some 
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early-life exposures. Low birth-weight and related perinatal risks predict late-life disease and 
mortality (Barker et al. 2002). Should records of perinatal exposures be available to trials of 
therapies to slow aging, they may prove useful. Fourth, our retrospective battery lacked recall 
of childhood health. Retrospective childhood health assessments are used in social surveys of 
older adults, and predict aging outcomes in these samples (Blackwell et al. 2001).  
 Our measurement of accelerated aging is necessarily imperfect. Methods are still under 
development to quantify biological aging. The one we used, Pace of Aging, is distinct from many 
others in that it is based on observations of change occurring over time within individuals. In 
contrast, most other methods are based on comparisons of chronologically older individuals to 
younger ones. In acknowledgement of this difference, we repeated our analysis using two such 
indexes, the “Biological Age” (Levine 2013), and an aging-related homeostatic dysregulation 
index (Cohen et al. 2013), and obtained similar results. Pace of Aging predicts many signs of 
foreshortened healthspan: faster Pace of Aging is related to poorer performance on tests of 
strength, balance, and motor coordination, signs of early-onset cognitive decline, and aged 
appearance already by midlife (Belsky, Caspi, Houts, et al. 2015). Biological Age and age-related 
homeostatic dysregulation predict mortality (Levine & Crimmins 2014; Li et al. 2015). 
Replication of findings with these indexes argues that our results are not sensitive to the 
specific method used to quantify biological aging. Nevertheless, further demonstrations with 
alternative methods of quantification can strengthen confidence in these findings.  
In sum, this article links together two separate streams of research. One stream 
addresses early-life exposures that shorten healthspan (Gluckman & Hanson 2004; Danese & 
McEwen 2012; Epel 2009). The other, geroscience, seeks to develop interventions that modify 
aging biology to lengthen healthspan (Kennedy et al. 2014; Burch et al. 2014; Ravussin et al. 
2015). Our analysis joins these streams at the life-course stage when they intersect: middle life. 
Our results show this linkage is sound, and suggest that measuring early-life personal histories 
of participants can benefit healthspan-extension trials. 
 
METHODS 
Sample 
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 Participants are members of the Dunedin Study, a longitudinal investigation of health and 
behavior in a representative birth cohort.  Study members (N=1,037; 91% of eligible births; 52% 
male) were all individuals born between April 1972 and March 1973 in Dunedin, New Zealand 
(NZ), who were eligible based on residence in the province and who participated in the first 
assessment at age 3 (Poulton et al. 2015).  The cohort represents the full range of 
socioeconomic status on NZ’s South Island and matches the NZ National Health and Nutrition 
Survey on key health indicators (e.g., BMI, smoking, GP visits) (Poulton et al. 2015). Cohort 
members are primarily white; fewer than 7% self-identify as having partial non-Caucasian 
ancestry, matching the South Island. Assessments were carried out at birth and ages 3, 5, 7, 9, 
11, 13, 15, 18, 21, 26, 32, and, most recently, 38 years, when 95% of the 1,007 Study members 
still alive took part. At each assessment, each Study member is brought to the research unit for 
a full day of interviews and examinations. The Otago Ethics Committee approved each phase of 
the study and informed consent was obtained from all Study members. 
 In addition to studying the full cohort, we used electronic medical record data to identify 
two subsamples within the cohort who had recent contact with the health care system. The 
first subsample comprises cohort members with recent pharmaceutical prescriptions. This 
subsample was identified via record linkage with the Pharmaceutical Management Agency 
(PHARMAC) database.  PHARMAC is the New Zealand Crown agency that selects and purchases 
medicines that are subsidized for use in the community (all common medications are on the 
list). The database represents a record of requests from pharmacists for payment of subsidies 
associated with prescriptions linked to the National Health Index (NHI) number, a unique 
identifier assigned to every person who accesses health-related support in New Zealand.  The 
second subsample comprises cohort members with recent hospital admissions.  This subsample 
was identified via record linkage with the New Zealand Ministry of Health.  The database 
contains information about admission events to nationwide hospitals and is linked to the NHI 
number. Both searches were conducted at the end of the last assessment (age 38 years) and 
here we report data about the time period since the previous assessment at age 32 years).   
 
Measuring the Pace of Aging 
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As described previously (Belsky, Caspi, Houts, et al. 2015), we measured Pace of Aging in 
n=954 Dunedin Study members with repeated assessments of a panel of 18 biomarkers taken 
at ages 26, 32, and 38 tears. The biomarkers were: Apolipoprotein B100/A1 ratio, Blood 
pressure (mean arterial pressure), Body mass index (BMI) and Waist-hip ratio, C-reactive 
protein and white blood cell count, Cardiorespiratory fitness (VO2Max), Creatinine clearance, 
Forced expiratory volume in one second (FEV1) and Forced vital capacity ratio (FEV1/FVC), 
Glycated hemoglobin, High density lipoprotein (HDL), Lipoprotein(a), Leukocyte telomere 
length (LTL), Periodontal disease, Total cholesterol, Triglycerides, Urea nitrogen. For each 
biomarker, we calculated the Study member’s personal rate of change using mixed-effects 
growth models. We combined these rates of change into a single index scaled in years of 
physiological change occurring per one chronological year. The average Study member had 
Pace of Aging equal to one year of physiological change per one chronological year. The fastest-
aging Study members experienced more than twice that rate of physiological change. The 
slowest-aging study members experienced almost no change at all. The resulting Pace of Aging 
measure took on a normal distribution with M=1, SD=0.38.  
Cross-sectional Biological Age at age 38 years. As described previously (Belsky, Caspi, 
Houts, et al. 2015), we calculated each Dunedin Study member’s Biological Age at age 38 years 
using the Klemera-Doubal equation (Klemera & Doubal 2006) and parameters estimated from 
the NHANES-III dataset (Levine 2013) for ten biomarkers (7 of which overlapped with Pace of 
Aging): Glycated hemoglobin, Forced expiratory volume in one second (FEV1), Blood pressure 
(systolic), Total cholesterol, C-reactive protein, Creatinine, Urea nitrogen, Albumin, Alkaline 
phosphatase, and Cytomegalovirus IgG. Biological Age took on a normal distribution, ranging 
from 28-61 years (M=38 years, SD=3.23).  
Cross-sectional age-related homeostatic dysregulation at age 38 years. We measured 
age-related homeostatic dysregulation by applying the biomarker Mahalanobis distance 
method described by Cohen and colleagues (Cohen et al. 2013; Li et al. 2015) to Study 
members’ age-38 biomarker values. Biomarker Mahalanobis distance measures how aberrant 
an individual’s physiology is relative to a reference norm (Cohen et al. 2013). Cohen and 
colleagues used chronologically young individuals to form this reference norm for their 
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calculations (Li et al. 2015). They interpreted biomarker Mahalanobis distance from the 
reference as an indicator of age-related homeostatic dysregulation, a sign of biological aging. 
We formed our reference from the Dunedin Study members’ biomarker values at age 26 years, 
the youngest age at which the biomarkers were measured. We then calculated Mahalanobis 
distance based on age-38 values of the 18 biomarkers included in Pace of Aging calculation. 
Thus, a Study member’s biomarker Mahalanobis distance quantifies decline in homeostatic 
regulation relative to the cohort’s age-26 norm. Distances were log transformed and 
standardized to have M=1, SD=0 for analysis. 
 
Measuring Personal Histories  
 We assessed 6 personal-history characteristics hypothesized to relate to biological aging 
using archival data prospectively collected beginning when Study members were children. The 
6 personal-history characteristics were familial longevity, childhood social class, adverse 
childhood experiences (ACEs), and childhood physical health, intelligence, and self-control. We 
also measured personal histories from contemporaneous measures including retrospective 
reports collected from Study members when they were adults. Details on personal history 
measurements are reported in the Supplementary Information.  
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Figure 1. Subgroups of normally distributed human pace of aging relevant to design of trials 
for healthspan-extension therapies. Pace of aging is the rate of coordinated decline in the 
integrity of bodily systems occurring with advancing chronological age. We showed that 
variation in the pace of aging could be quantified already in individuals still too young to have 
age-related disease by tracking changes in biomarkers of organ-system functioning over time 
(Belsky, Caspi, Houts, et al. 2015). We earlier reported  that individuals whose physiology 
changed more slowly with the passage of chronological time (light blue segment of distribution) 
experienced better physical and cognitive functional outcomes in aging, and also showed fewer 
subjective signs of aging. The opposite was true of those whose physiology changed more 
rapidly (red segment of distribution). Both slower and faster aging population segments are 
needed in research to develop healthspan-extension therapies. Slower aging populations may 
provide clues to novel therapeutic targets. Faster aging populations are those who therapies 
must benefit. 
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Figure 2. Family and childhood characteristics are associated with Study members’ Pace of 
Aging from age 26-38 years. Figure cells graph associations between 6 family and childhood 
characteristics (x-axis variables) and Study members’ Pace of Aging measured from changes in 
18 biomarkers measured across ages 26, 32, and 38 years (y-axis). Age of longest-lived 
grandparent was measured from reports by Study members’ parents. Childhood social class, 
exposure to adverse childhood experiences, childhood health, childhood IQ, and childhood self-
control were assessed using previously established methodology applied to archival Dunedin 
Study records including exams and testing, reports by parents and teachers, clinician ratings, 
and direct observations. Figures show “binned” scatterplots in which each plotted point reflects 
average x- and y-coordinates for “bins” of approximately 20 Study members. Regression lines 
and effect-size estimates were estimated from the original, un-binned data.  
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Figure 3. Cumulative prospectively-assessed personal-history risks in Study members with 
slow, average, and fast Pace of Aging. Panel A graphs density plots of cumulative risk scores 
for Study members with slow, average, and fast Pace of Aging. The cumulative risk score 
reflects total burden of risk across 6 personal-history characteristics (grandparent longevity, 
family social class during childhood, adverse childhood experiences, childhood IQ score, 
childhood self control, and childhood health). For each characteristic, values were standardized 
to a T distribution (M=50, SD=10) with high scores reflecting increased risk (e.g. shorter-lived 
grandparents, lower childhood social class). Standardized values were summed to calculate the 
cumulative risk score. Thus, the expected cumulative risk level was 300. The graph shows that 
2/3 of the slow-aging group had below this expected level of risk. In contrast, less than 1/3 of 
the fast-aging group did.  Panel B graphs proportions of Study members with slow, average, 
and fast Pace of Aging who were classified as high-risk on 0, 1, or 2-or-more of the 6 
characteristics. High risk classifications were for having short-lived grandparents (no 
grandparent survived past age 80 years), growing up in a low-social class family, exposure to 4 
or more adverse childhood experiences, childhood IQ score ≤1 SD below the population mean 
(a score of 85 or below), childhood self-control score ≤1 SD below the population mean, and 
childhood health score ≤1 SD below the population mean. The graph shows that most slow-
aging Study members had no high-risk classifications. In contrast, more than 40% of the fast-
aging Study members were classified as high-risk on multiple family and childhood 
characteristics.  
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Figure 4. Proportions of slow-, average-, and fast-Pace of Aging Study members classified as 
high-risk on 0, 1, or 2-or-more family and childhood characteristics based on 
contemporaneous assessments conducted in adulthood. Risk factors were having short-lived 
grandparents (no grandparent survived past age 80 years), retrospective report by the Study 
member that their parents held low-status occupations during the Study member’s childhood, 
retrospective report of exposure to 4 or more adverse childhood experiences, not holding any 
educational credential, and being rated by an examining nurse as having low levels of the 
personality trait conscientiousness. Panel A graphs results for the full cohort. The pattern is the 
same as when risk was classified from assessments during childhood. Most slow-aging Study 
members were not classified as high-risk on any family or childhood characteristic. In contrast, 
more than 40% of the fast-aging Study members were classified as high-risk on multiple family 
and childhood characteristics. Panels B and C repeat the analysis for subsamples of cohort 
members with recent contacts with the health care system and who may reflect the population 
most accessible to recruitment into clinical trials. Panel B graphs results for Study members 
with a recent prescription fill. Panel C graphs results for Study members with a recent hospital 
admission (excluding for pregnancy-related services).  
